The market bounced back Monday after a rough week last week. We are not out of the woods yet as a huge CPI report looms on ...

Illumina (NASDAQ: ILMN) a global leader in genomics, and LGC Biosearch Technologies™, a pioneer in agricultural genomics, ...

2 Scientists are designing FFPE sample-tailored RNA library preparation protocols, reagents, and kits to remove this bottleneck. Twist Bioscience, for example, offers a rapid library preparation kit ...

By combining Biosearch Technologies' targeted genotyping-by-sequencing library preparation ... s Grail acquisition. Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array ...

Element Biosciences’ bid to claim a slice of a DNA sequencing technology market dominated by Illumina has been helped by an impressive $277 million financing round backed by a wide range of ...

BENGALURU: Illumina, a global leader in DNA sequencing and array-based technologies, announced it will establish a Global CapabilityCenter in Bengaluru to expand its technology workforce in ...

RNA modulates transcription factor binding to DNA, though the subsequent effect on transcription remains unclear. The study ...

The DNA sequencing and array-based technologies provider noted that the court ruled that the European Commission did not have jurisdiction over Illumina's acquisition of GRAIL. According to the ...